Antibiotics

View Details

Major antibiotics classes

notion image

Antimicrobial drugs

Ending
Category
Example
‑asvir
NS5A inhibitor
Ledipasvir
‑bendazole
Antiparasitic/antihelminthic
Mebendazole
‑buvir
NS5B inhibitor
Sofosbuvir
‑cillin
Transpeptidase inhibitor
Ampicillin
‑conazole
Ergosterol synthesis inhibitor
Ketoconazole
‑cycline
Protein synthesis inhibitor
Tetracycline
‑floxacin
Fluoroquinolone
Ciprofloxacin
‑mivir
Neuraminidase inhibitor
Oseltamivir
‑navir
Protease inhibitor
Ritonavir
‑ovir
Viral DNA polymerase inhibitor
Acyclovir
‑previr
NS3/4A inhibitor
Grazoprevir
‑tegravir
Integrase inhibitor
Dolutegravir
‑thromycin
Macrolide
Azithromycin

Antimicrobial therapy

notion image
  • Gentamicin ototoxicity can generate free radicals within the inner ear, leading to permanent damage to sensory hair cells (HCs) and eventually hearing loss.

Antibiotics by class

Antibiotics
Example(s)
Mechanism
Coverage and resistance
Beta‑lactam
Penicillins
Amoxicillin, Flucloxacillin, Co‑amoxiclav, Piperacillin–tazobactam
Cell wall synthesis inhibitors
Penicillin V/G: gram positives. Amoxicillin: as penicillin plus gram‑negative rods. Flucloxacillin: as penicillin plus MSSA. Piperacillin: gram positives plus Pseudomonas, gram‑negative rods, and anaerobes. Beta‑lactamases confer resistance, overcome by combining with beta‑lactamase inhibitors (e.g. clavulanic acid, tazobactam).
Carbapenems
Meropenem
Cell wall synthesis inhibitors
Broad‑spectrum gram positive, gram negative, and anaerobic; not active against MRSA.
Cephalosporins
Cefuroxime (2nd gen), Ceftriaxone (3rd), Ceftazidime (3rd)
Cell wall synthesis inhibitors
With newer generations, gram‑positive cover decreases and gram‑negative cover increases.
Monobactam
Aztreonam
Cell wall synthesis inhibitors
Gram‑negative aerobes only.
Antiribosomal
Aminoglycosides
Gentamicin
Protein synthesis inhibitors
Gram‑negative aerobic bacteria.
Macrolides
Erythromycin, Clarithromycin
Protein synthesis inhibitors
Atypicals (Legionella, Mycoplasma, Chlamydia) and some gram‑positive cocci.
Tetracyclines
Tetracycline
Protein synthesis inhibitors
Intracellular pathogens and specific gram negatives.
Lincosamides
Clindamycin
Protein synthesis inhibitors
Anaerobes and some aerobic gram positives, including MRSA but not enterococci.
Amphenicol
Chloramphenicol
Protein synthesis inhibitors
Broad‑spectrum (gram positive, gram negative, and anaerobes) but limited use because of high toxicity.
Oxazolidinones
Linezolid
Protein synthesis inhibitors
Gram positives including MRSA and VRE; no activity against most gram negatives.
Others
Fluoroquinolones
Ciprofloxacin (2nd gen), Levofloxacin (3rd), Moxifloxacin (4th)
DNA gyrase inhibitor
Narrow gram‑negative coverage (1st gen) plus atypicals (2nd gen) plus Streptococcus (3rd gen) plus anaerobes (4th gen).
Nitroimidazoles/furans
Metronidazole, Nitrofurantoin
Enzyme damage and DNA damage
Metronidazole: gram negatives and enteric anaerobes.
Glycopeptides
Vancomycin
Cell wall synthesis inhibitor
Gram positives including MRSA; oral formulation used to treat gut Clostridioides difficile colitis.
Lipopeptides
Daptomycin
Cell membrane dysfunction
Gram‑positive organisms including methicillin‑ and vancomycin‑resistant strains.
Antimetabolites
Trimethoprim, Sulfamethoxazole
Folate synthesis inhibitor
Gram positives and gram negatives; also used for parasites including Toxoplasma and Pneumocystis jirovecii.
  • Aminoglycosides: Nephrotoxicity, neuromuscular blockade (higher risk with (succinylcholine, curare-like drugs), ototoxicity (cochlear and vestibular)
  • Fluoroquinolones: GI upset, headache, dizziness, mood changes, impaired glucose tolerance, retinopathy, bone and cartilage anomalies like Achilles tendon rupture, prolongation of QTc, pseudomembranous colitis, photosensitivity, exacerbates myasthenia gravis
  • Chloramphenicol: Aplastic anemia, “gray baby” syndrome, optic and peripheral neuritis
  • Macrolides: Increased GIT motility, diarrhea, hypersensitivity reactions, erythromycin shows QTc prolongation, cholestatic jaundice, tinnitus and deafness; clarithromycin and erythromycin are potent inhibitors of cyt P450
  • Telithromycin: Exacerbates myasthenia gravis hence contraindicated, liver failure, hepatitis, prolongation of QTc, inhibits CYP3A4
  • Colistin and Polymyxin B: Nephrotoxicity (ATN, hematuria, casts), neurotoxicity, paresthesias, vertigo, ataxia, visual defects, neuromuscular blockade, hypersensitivity, chest tightness, bronchoconstriction
  • Tetracyclines: Yellowing of teeth, vestibular problems like dizziness, vertigo, pseudomembranous colitis, photosensitivity, fatty liver, risk of esophageal ulcerations; increase the effect of oral anticoagulants
  • Tigecycline: GI upset, diarrhea, hepatotoxicity, photosensitivity
  • Sulfonamides: Stevens-Johnson syndrome, crystalluria, kernicterus
  • Trimethoprim plus sulfamethoxazole: All adverse effects of sulfonamides plus folate deficiency, hyperkalemia, renal insufficiency, increases levels of warfarin, phenytoin, rifampin and methotrexate causes hypoglycemia when combined with sulfonylureas
  • Rifampin: Orange-red discoloration of skin and body fluids, jaundice, monitor LFTs
  • Metronidazole: Neuropathy, GI upset, headache, seizures, disulfiram-like effect with alcohol, dark urine, reduce dose in liver disease, increases anticoagulant effect of warfarin
  • Linezolid: Increased serum lactic acid, myelosuppression, neuropathy, serotonin syndrome, optic neuritis
  • Lincosamides: Neuromuscular blockade, C.difficile colitis
  • Isoniazid: Hepatitis, jaundice
  • Clindamycin: Pseudomembranous colitis, esophagitis and esophageal ulceration, hypersensitivity
  • Daptomycin: Myopathy, increased creatine kinase, eosinophilic pneumonia
  • Carbapenems: GI upset, seizures (imipenem), adjust dose of ertapenem and meropenem in renal insufficiency
  • Cephalosporins: Pseudomembranous colitis, hypersensitivity reactions, leukopenia, thrombocytopenia, Coombs positive hemolytic anemia; cefotetan shows disulfiram-like effect with ethanol and elevates PT, INR and PTT
  • Penicillins: Hypersensitivity reactions, rashes, anaphylaxis, urticaria, angioedema, serum sickness, exfoliative dermatitis, seizures, nephritis, pseudomembranous colitis, Coombs positive hemolytic anemia, leukopenia, thrombocytopenia, GI upset, ticarcillin causes bleeding tendency in patients with renal failure
  • Monobactam (aztreonam): Phlebitis, rash, elevated LFTs, adjust dose in renal failure
  • Quinupristin/Dalfopristin: Phlebitis, arthralgia, myalgia, hyperbilirubinemia, decrease dose in liver disease
  • Vancomycin: Hypersensitivity reactions like rash, fever, neutropenia, phlebitis, “red man” syndrome due to histamine release, monitor renal function